Figure 1From: Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study in ratsPCSK9 levels during the treatment with placebo, ezetimibe, Xuezhikang, Xuezhikang plus ezetimibe, pitavastatin and pitavastatin plus ezetimibe. * p < 0.05 versus placebo group. XZK: Xuezhikang.Back to article page